352 related articles for article (PubMed ID: 18617225)
1. Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial function.
Gresele P; Migliacci R; Vedovati MC; Ruffatti A; Becattini C; Facco M; Guglielmini G; Boscaro E; Mezzasoma AM; Momi S; Pengo V
Thromb Res; 2009; 123(3):444-51. PubMed ID: 18617225
[TBL] [Abstract][Full Text] [Related]
2. Patients with antiphospholipid syndrome display endothelial perturbation.
Cugno M; Borghi MO; Lonati LM; Ghiadoni L; Gerosa M; Grossi C; De Angelis V; Magnaghi G; Tincani A; Mari D; Riboldi P; Meroni PL
J Autoimmun; 2010 Mar; 34(2):105-10. PubMed ID: 19656656
[TBL] [Abstract][Full Text] [Related]
3. Endothelial function is impaired in patients with primary antiphospholipid syndrome.
Stalc M; Poredos P; Peternel P; Tomsic M; Sebestjen M; Kveder T
Thromb Res; 2006; 118(4):455-61. PubMed ID: 16274735
[TBL] [Abstract][Full Text] [Related]
4. Endothelial dysfunction in patients with kidney failure and vascular risk factors: acute effects of hemodialysis.
Migliacci R; Falcinelli F; Imperiali P; Floridi A; Nenci GG; Gresele P
Ital Heart J; 2004 May; 5(5):371-7. PubMed ID: 15185901
[TBL] [Abstract][Full Text] [Related]
5. Systemic endothelial cell markers in primary antiphospholipid syndrome.
Williams FM; Parmar K; Hughes GR; Hunt BJ
Thromb Haemost; 2000 Nov; 84(5):742-6. PubMed ID: 11127848
[TBL] [Abstract][Full Text] [Related]
6. High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction.
Lee KW; Blann AD; Lip GY
Am J Hypertens; 2005 Jan; 18(1):104-15. PubMed ID: 15691624
[TBL] [Abstract][Full Text] [Related]
7. Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies.
Jy W; Tiede M; Bidot CJ; Horstman LL; Jimenez JJ; Chirinos J; Ahn YS
Thromb Res; 2007; 121(3):319-25. PubMed ID: 17582471
[TBL] [Abstract][Full Text] [Related]
8. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
[TBL] [Abstract][Full Text] [Related]
9. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
Freestone B; Chong AY; Nuttall S; Lip GY
Thromb Res; 2008; 122(1):85-90. PubMed ID: 17996280
[TBL] [Abstract][Full Text] [Related]
10. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.
Kerekes G; Szekanecz Z; Dér H; Sándor Z; Lakos G; Muszbek L; Csipö I; Sipka S; Seres I; Paragh G; Kappelmayer J; Szomják E; Veres K; Szegedi G; Shoenfeld Y; Soltész P
J Rheumatol; 2008 Mar; 35(3):398-406. PubMed ID: 18203326
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory response and the endothelium.
Meroni PL; Borghi MO; Raschi E; Ventura D; Sarzi Puttini PC; Atzeni F; Lonati L; Parati G; Tincani A; Mari D; Tedesco F
Thromb Res; 2004; 114(5-6):329-34. PubMed ID: 15507262
[TBL] [Abstract][Full Text] [Related]
12. [Endothelial function in high risk cardiovascular patients].
Káli A; Jánosi A
Orv Hetil; 2006 Jan; 147(3):99-106. PubMed ID: 16515028
[TBL] [Abstract][Full Text] [Related]
13. Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell response.
Conti F; Spinelli FR; Alessandri C; Pacelli M; Ceccarelli F; Marocchi E; Montali A; Capozzi A; Buttari B; Profumo E; Sorice M; Arca M; Valesini G; Riganò R
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):661-8. PubMed ID: 24436371
[TBL] [Abstract][Full Text] [Related]
14. Vascular damage correlates between heparin-induced thrombocytopenia and the antiphospholipid syndrome.
Walenga JM; Michal K; Hoppensteadt D; Wood JJ; Robinson JA; Bick RL
Clin Appl Thromb Hemost; 1999 Oct; 5 Suppl 1():S76-84. PubMed ID: 10726041
[TBL] [Abstract][Full Text] [Related]
15. Lipid peroxidation as risk factor for endothelial dysfunction in antiphospholipid syndrome patients.
Stanisavljevic N; Stojanovich L; Marisavljevic D; Djokovic A; Dopsaj V; Kotur-Stevuljevic J; Martinovic J; Memon L; Radovanovic S; Todic B; Lisulov D
Clin Rheumatol; 2016 Oct; 35(10):2485-93. PubMed ID: 27562033
[TBL] [Abstract][Full Text] [Related]
16. Periodontal disease is associated with brachial artery endothelial dysfunction and systemic inflammation.
Amar S; Gokce N; Morgan S; Loukideli M; Van Dyke TE; Vita JA
Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1245-9. PubMed ID: 12763762
[TBL] [Abstract][Full Text] [Related]
17. Severe endothelial dysfunction in young women with polycystic ovary syndrome is only partially explained by known cardiovascular risk factors.
Sorensen MB; Franks S; Robertson C; Pennell DJ; Collins P
Clin Endocrinol (Oxf); 2006 Nov; 65(5):655-9. PubMed ID: 17054469
[TBL] [Abstract][Full Text] [Related]
18. [Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome].
Reshetniak TM; Seredavkina nV; Mach ES; Aleksandrova EN; Novikov AA; Cherkasova MV; Nasonov EL
Ter Arkh; 2008; 80(10):60-7. PubMed ID: 19105418
[TBL] [Abstract][Full Text] [Related]
19. Circulating levels of high-sensitivity C-reactive protein and soluble markers of vascular endothelial cell activation in growth hormone-deficient adolescents.
Lanes R; Marcano H; Villaroel O; Gunczler P; Morillo E; Paoli M; Perez M; Maulino N; Palacios A
Horm Res; 2008; 70(4):230-5. PubMed ID: 18772596
[TBL] [Abstract][Full Text] [Related]
20. Biochemical markers of endothelial activation in primary hyperparathyroidism.
Fallo F; Cella G; Casonato A; Ermani M; Vettor R; Zanella S; Lumachi F
Horm Metab Res; 2006 Feb; 38(2):125-9. PubMed ID: 16523414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
